China has reaffirmed its willingness to collaborate with the United States in addressing the fentanyl crisis but emphasized the need for "concrete actions" from Washington to enable effective cooperation. Speaking at a press briefing on Wednesday, Chinese Foreign Ministry spokesperson Guo Jiakun expressed sympathy for Americans affected by the opioid epidemic and highlighted China’s “strictest and most thorough” anti-drug policies.
Guo noted that China has already provided assistance to the U.S., achieving “positive results,” and remains open to further collaboration. However, he stressed that the U.S. must create “necessary conditions” for sustained progress, without specifying details. China currently controls more narcotic substances than most countries, according to Guo, underscoring its role as a global leader in drug regulation.
The remarks come amid ongoing discussions about cross-border efforts to combat synthetic drug trafficking. Analysts suggest China’s stance reflects its broader approach to bilateral cooperation, balancing humanitarian engagement with calls for reciprocal commitment. For businesses and policymakers, the development signals potential opportunities for cross-strait collaboration in pharmaceutical regulation and public health initiatives.
As the fentanyl crisis continues to impact communities worldwide, China’s proactive measures and emphasis on mutual responsibility offer a framework for addressing transnational challenges. The dialogue also underscores Asia’s growing influence in shaping global health and security agendas.
